Hudson Bay Capital Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
PAI
Hudson Bay Capital Management's BLUE Position: Q2 2024 in Review
Hudson Bay Capital Management sold out of bluebird bio (BLUE) in Q2 2024, closing a stake of 59,006 shares — an estimated $1.51M sold.
Hudson Bay Capital Management first reported a position in BLUE in Q3 2018 and held it in 13 quarters. The position peaked at $5.72M in Q2 2019. 150 funds tracked by Wall St. Rank hold BLUE as of Q2 2024.
- Hudson Bay Capital Management reported no remaining bluebird bio position as of Q2 2024 after selling out during the quarter.
- Hudson Bay Capital Management sold 59,006 bluebird bio shares in Q2 2024, an estimated $1.51M.
- Hudson Bay Capital Management first reported a position in bluebird bio in Q3 2018 and held it in 13 quarters.
- Hudson Bay Capital Management's bluebird bio position peaked at $5.72M in Q2 2019.
- 150 funds tracked by Wall St. Rank held bluebird bio as of Q2 2024.
Based on Hudson Bay Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.